Literature DB >> 30269784

Detection of non-notifiable H4N6 avian influenza virus in poultry in Great Britain.

Scott M Reid1, Sharon M Brookes2, Alejandro Núñez3, Jill Banks2, C Daniel Parker4, Vanessa Ceeraz2, Christine Russell2, Amanda Seekings2, Saumya S Thomas2, Anita Puranik2, Ian H Brown2.   

Abstract

A 12-month pilot project for notifiable avian disease (NAD) exclusion testing in chicken and turkey flocks in Great Britain (GB) offered, in partnership with industry, opportunities to carry out differential diagnosis in flocks where NAD was not suspected, and to identify undetected or undiagnosed infections. In May 2014, clinical samples received from a broiler breeder chicken premises that had been experiencing health and production problems for approximately one week tested positive by avian influenza (AI) real-time reverse transcription polymerase chain reaction (RRT-PCR). Following immediate escalation to an official, statutory investigation to rule out the presence of notifiable AI virus (AIV; H5 or H7 subtypes), a non-notifiable H4N6 low pathogenicity (LP) AIV was detected through virus isolation in embryonated specific pathogen free (SPF) fowls' eggs, neuraminidase inhibition test, cleavage site sequencing and AIV subtype H4-specific serology. Premises movement restrictions were lifted, and no further disease control measures were implemented as per the United Kingdom (UK) legislation. Phylogenetic analysis of the haemagglutinin and neuraminidase genes of the virus revealed closest relationships to viruses from Mallard ducks in Sweden during 2007 and 2009. In June 2014, clinical suspicion of NAD was reported in a flock of free-range laying chickens elsewhere in GB, due to increasing daily mortality and reduced egg production over a five-day period. An H4N6 LPAIV with an intravenous pathogenicity index of 0.50 was isolated. This virus was genetically highly similar, but not identical, to the virus detected during May 2014. Full viral genome analyses showed characteristics of a strain that had not recently transferred from wild birds, implying spread within the poultry sector had occurred. A stalk deletion in the neuraminidase gene sequence indicated an adaptation of the virus to poultry. Furthermore, there was unexpected evidence of systemic spread of the virus on post-mortem. No other cases were reported. Infection with LPAIVs often result in variable clinical presentation in poultry, making detection of disease more difficult. Crown
Copyright © 2018. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Avian influenza A virus; Broiler breeders; Commercial layer chickens; Non-notifiable avian influenza virus; Notifiable avian disease ‘testing to exclude’ scheme; Surveillance for avian influenza; ‘Stalk deletion’

Mesh:

Substances:

Year:  2018        PMID: 30269784     DOI: 10.1016/j.vetmic.2018.08.026

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  3 in total

1.  The Emergence of H7N7 Highly Pathogenic Avian Influenza Virus from Low Pathogenicity Avian Influenza Virus Using an in ovo Embryo Culture Model.

Authors:  Amanda H Seekings; Wendy A Howard; Alejandro Nuñéz; Marek J Slomka; Ashley C Banyard; Daniel Hicks; Richard J Ellis; Javier Nuñéz-García; Lorian C Hartgroves; Wendy S Barclay; Jill Banks; Ian H Brown
Journal:  Viruses       Date:  2020-08-21       Impact factor: 5.048

2.  A universal RT-qPCR assay for "One Health" detection of influenza A viruses.

Authors:  Alexander Nagy; Lenka Černíková; Kateřina Kunteová; Zuzana Dirbáková; Saumya S Thomas; Marek J Slomka; Ádám Dán; Tünde Varga; Martina Máté; Helena Jiřincová; Ian H Brown
Journal:  PLoS One       Date:  2021-01-20       Impact factor: 3.240

3.  A Turkey-origin H9N2 Avian Influenza Virus Shows Low Pathogenicity but Different Within-Host Diversity in Experimentally Infected Turkeys, Quail and Ducks.

Authors:  Edyta Świętoń; Karolina Tarasiuk; Monika Olszewska-Tomczyk; Ewelina Iwan; Krzysztof Śmietanka
Journal:  Viruses       Date:  2020-03-16       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.